ONCOCYTE CORPORATION AND [●], AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [●], 20[●] ONCOCYTE CORPORATION FORM OF PREFERRED STOCK WARRANT AGREEMENTWarrant Agreement • October 2nd, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ONCOCYTE CORPORATION, a California corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
ONCOCYTE CORPORATION AND [●], AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [●], 20[●] ONCOCYTE CORPORATION FORM OF DEBT SECURITIES WARRANT AGREEMENTWarrant Agreement • October 2nd, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between ONCOCYTE CORPORATION, a California corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
